Medicef Pharma Limited - Company Profile

It is a pharma public limited company based in Kasauli, Himachal Pradesh, India, established in 2012.
2012 Kasauli, Himachal Pradesh, India Active
Last Updated:
Access Report
About Medicef Pharma Limited

Medicef Pharma Limited, a active public limited company, was established on 16 October 2012 in Kasauli, Himachal Pradesh, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24100HP2012PLC011243. Registered under ROC Roc Himachal Pradesh. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹0.10 M.

Formerly known as Medicef Pharma Private Limited. It upholds a compliant status. Its leadership includes Nilesh Narendrakumar Ranka (Director), Parveen Kumar (Director), Dhananjay Kumar Vishwakarma (Director). Past directors included Vijay Kumar Aggarwal, Sanjeev Goel, Vivek Kumar Rana. It holds ₹36.92 Cr open charges and ₹10.45 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 28, 29 & 48, Phase - 1, Epip, Jharmajri, Kasauli, Himachal Pradesh, 174103.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100HP2012PLC011243

  • Registration Number

    011243

  • Incorporation Date

    16 October 2012

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Himachal Pradesh

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 0.10 M
  • Company Age 13 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 36.92 Cr
  • Satisfied Charges ₹ 10.45 Cr
  • Revenue Growth **** %
  • Profit Growth **** -149555.14%
  • Ebitda **** -36499.86%
  • Net Worth -18199.58%
  • Total Assets **** 195983.45%
Company report

Medicef Pharma Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Medicef Pharma Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Medicef Pharma Limited?
Current Directors
Name Designation Appointment Date Status
Nilesh Narendrakumar Ranka Director 12 Feb 2024 Current
Parveen Kumar Director 29 Jan 2024 Current
Dhananjay Kumar Vishwakarma Director 29 Jan 2024 Current
Anish Kumar Rana Director 29 Jan 2024 Current
Satyanaraian Gupta Director 29 Jan 2024 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 30 Jan 2024 Past
Pramod Abcsdd Director 23 Jul 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Additional Director 29 Sep 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Medicef Pharma.

Medicef Pharma Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 149555.14% decrease in profit. The company's net worth observed a substantial decline by a decrease of 18199.58%.

Medicef Pharma revenue growth over time
Medicef Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 195983.45%
*******
*******
*******
*******
Profit or Loss
*******
 -149555.14%
*******
*******
*******
*******
Net Worth
*******
 -18199.58%
*******
*******
*******
*******
EBITDA
*******
 -36499.86%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Medicef Pharma?

In 2023, Medicef Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹369,200,000.00

Satisfied Charges

₹104,500,000.00

Charges Breakdown by Lending Institutions
  • Dbs Bank Ltd : 25.00 Cr
  • Others : 11.92 Cr
Latest Charge Details
Date Lender Amount Status
19 Feb 2024 Dbs Bank Ltd ₹25.00 Cr Open
20 Sep 2023 Others ₹9.42 Cr Open
20 Sep 2023 Others ₹5.00 M Open
20 Sep 2023 Others ₹2.00 Cr Open
26 Aug 2022 Others ₹5.00 M Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Medicef Pharma?

Unlock and access historical data on people associated with Medicef Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Medicef Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medicef Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Medicef Pharma
Recent Activity within the Organization
  • Charges

    The activity A charge with Dbs Bank Ltd of Rs. 25.00 Cr registered on 19 Feb 2024 with Charge ID 100868649 was modified on 30 Jan 2025. was completed.

  • Charges

    A charge with Others of Rs. 9.42 Cr registered on 20 Sep 2023 with Charge ID 100788792 was modified on 30 Jan 2025. was recorded as a recent event.

  • Charges

    Progress on A charge with Others of Rs. 0.50 Cr registered on 20 Sep 2023 with Charge ID 100788791 was modified on 30 Jan 2025. was documented.

  • Annual General Meeting

    Progress on Medicef Pharma Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.

  • Balance Sheet

    Medicef Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Himachal Pradesh. was recorded as a recent event.

  • Charges

    The activity A charge with Dbs Bank Ltd amounted to Rs. 25.00 Cr with Charge ID 100868649 was registered on 19 Feb 2024. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Medicef Pharma Limited?

The CIN of Medicef Pharma Limited is U24100HP2012PLC011243.

Where is Medicef Pharma Limited headquartered?

Medicef Pharma Limited is headquartered at Plot No. 28, 29 & 48, Phase - 1, Epip, Jharmajri, Kasauli, Himachal Pradesh, 174103.

When was Medicef Pharma Limited incorporated?

Medicef Pharma Limited was incorporated on 16 October 2012.

Who are the current directors of Medicef Pharma Limited?

The current directors of Medicef Pharma Limited are

What is the primary industry of Medicef Pharma Limited?

The primary industry of Medicef Pharma Limited is Trade.

Is Medicef Pharma Limited a listed company?

Medicef Pharma Limited is unlisted.

What is the capital structure of Medicef Pharma Limited?

The authorized capital of Medicef Pharma Limited is ₹5.00 Cr, and the paid-up capital is ₹0.10 M.

What is the compliance status of Medicef Pharma Limited?

The compliance status of Medicef Pharma Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available